FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to new derivatives of phenyl- and aminophenylalkylsulfonamide of the formula: wherein A means (R1SO2NR2-), (R3R60NSO2NR2-); X means -NH-, -CH2- or -OCH2-; Y means 2-imidazoline, 2-oxazoline or 4-imidazole; R1 means (lower)-alkyl or phenyl; each of R2, R3, R60 means independently each of other means hydrogen atom, (lower)-alkyl or phenyl; each of R4, R5, R6, R7 independently each of other means hydrogen atom, (lower)-alkyl, -CF3, (lower)-alkoxy-group, halogen atom, phenyl, (lower)-alkenyl, hydroxyl, (lower)-alkylsulfonamide or (lower)-cycloalkyl wherein R2 and R7 in common can form optionally alkylene or alkenylene with 2-3 carbon atoms in unsubstituted or optionally substituted 5- or 6-membered ring wherein optional substituents in ring are halogen atoms, (lower)-alkyls or -CN under condition that when R7 means hydroxyl or (lower)-alkylsulfonamide then X doesn't mean -NH- when Y means 2-imidazoline. Invention relates also to pharmaceutically acceptable salts and to pharmaceutical composition based on thereof designated for regulation of physiological phenomena associated with substances eliciting affinity to α1A/1L-adrenoceptors. Invention provides preparing new biologically active compounds and medicinal agents based on thereof for using in medicine. EFFECT: valuable medicinal properties of compounds. 16 cl, 5 tbl, 18 ex
Authors
Dates
2003-12-10—Published
1998-06-22—Filed